Literature DB >> 8534268

Antitumor 2,3-dihydro-2-(aryl)-4(1H)-quinazolinone derivatives. Interactions with tubulin.

E Hamel1, C M Lin, J Plowman, H K Wang, K H Lee, K D Paull.   

Abstract

A series of derivatives of 2,3-dihydro-2-(aryl)-4(1H)-quinazolinone (DHQZ) with known antitumor activity was re-evaluated in the National Cancer Institute cancer cell line screen. Analysis by the COMPARE algorithm suggested that their cytotoxicity derived from interactions with tubulin. Significant inhibition of tubulin assembly and of the binding of radiolabeled colchicine to tubulin was demonstrated with several of the compounds, particularly NSC 145669, 175635, and 175636. The DHQZ derivatives are structurally analogous to a number of antimitotic agents, flavonols and derivatives of 2-styrylquinazolin-4(3H)-one and of 2-phenyl-4-quinolone. Structure-activity analogies between these agents, the combretastatins, and the colchicinoids were analyzed and summarized.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8534268     DOI: 10.1016/0006-2952(95)02156-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  12 in total

1.  Consumption of food groups and the risk of pancreatic cancer: a case-control study.

Authors:  Parviz Ghadirian; André Nkondjock
Journal:  J Gastrointest Cancer       Date:  2010-06

2.  Identification of diaryl 5-amino-1,2,4-oxadiazoles as tubulin inhibitors: the special case of 3-(2-fluorophenyl)-5-(4-methoxyphenyl)amino-1,2,4-oxadiazole.

Authors:  Andrei A Gakh; Andrey V Sosnov; Mikhail Krasavin; Tam Luong Nguyen; Ernest Hamel
Journal:  Bioorg Med Chem Lett       Date:  2013-01-11       Impact factor: 2.823

3.  Cytotoxic Activity and Three-Dimensional Quantitative Structure Activity Relationship of 2-Aryl-1,8-naphthyridin-4-ones.

Authors:  Yong Jin Kim; Eun Ae Kim; Mi Lyang Chung; Chaeuk Im
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

4.  Synthesis and in vitro antiproliferative activity against human cancer cell lines of novel 5-(4-methyl-benzylidene)-thiazolidine-2,4-diones.

Authors:  S Chandrappa; S B Benaka Prasad; K Vinaya; C S Ananda Kumar; N R Thimmegowda; K S Rangappa
Journal:  Invest New Drugs       Date:  2008-05-13       Impact factor: 3.850

5.  Synthesis and antiviral bioactivities of 2-aryl- or 2-methyl-3-(substituted- benzalamino)-4(3H)-quinazolinone derivatives.

Authors:  Xingwen Gao; Xuejian Cai; Kai Yan; Baoan Song; Lili Gao; Zhuo Chen
Journal:  Molecules       Date:  2007-12-27       Impact factor: 4.411

Review 6.  Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids.

Authors:  Prashant S Auti; Ginson George; Atish T Paul
Journal:  RSC Adv       Date:  2020-11-12       Impact factor: 4.036

7.  Identification of novel microtubule inhibitors effective in fission yeast and human cells and their effects on breast cancer cell lines.

Authors:  Jun Morishita; Paul Nurse
Journal:  Open Biol       Date:  2021-09-08       Impact factor: 6.411

Review 8.  A Review of the Recent Developments of Molecular Hybrids Targeting Tubulin Polymerization.

Authors:  Oluwakemi Ebenezer; Michael Shapi; Jack A Tuszynski
Journal:  Int J Mol Sci       Date:  2022-04-04       Impact factor: 5.923

9.  Uses of 2-ethoxy-4(3H) quinazolinone in synthesis of quinazoline and quinazolinone derivatives of antimicrobial activity: the solvent effect.

Authors:  Maher A El-Hashash; Sameh A Rizk; Khalid M Darwish; Fakhry A El-Bassiouny
Journal:  Glob J Health Sci       Date:  2011-12-29

10.  Synthesis, tautomeric structure and antimicrobial activity of 3-arylhydrazono-4-phenyl-[1,2,4]-triazepino[2,3-a]quinazoline-2,7(1H)-diones.

Authors:  Thoraya Abdel Reheem Farghaly; Mastoura Mohamed Edrees; Mosselhi Abdelnabi Mosselhi
Journal:  Molecules       Date:  2012-07-13       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.